sur OncoveryCare
OncoveryCare Secures $4.5M Seed Round and Partners with Tennessee Oncology
OncoveryCare, previously known as VivorCare, has completed an oversubscribed $4.5 million seed financing round. Led by .406 Ventures and supported by the McKay Institute for Oncology Transformation at Tennessee Oncology, the funding aims to revolutionize cancer survivorship care. Tennessee Oncology, a key player treating half of Tennessee's cancer patients, also joins hands with OncoveryCare in this initiative.
With U.S. cancer survivor numbers expected to double between 2008 and 2030, OncoveryCare’s mission addresses the fragmented and costly current care model. As survival rates improve, the need for managing complex health challenges post-treatment becomes more critical. OncoveryCare's virtual care model offers survivors customized support, tackling issues such as cardiotoxicity, mental health, and comprehensive care planning.
This partnership facilitates the deployment of OncoveryCare’s model across Tennessee Oncology’s extensive network, supported by the innovation-driven McKay Institute. Led by experienced professionals, the initiative aims to extend OncoveryCare's impact nationwide, offering efficient and effective cancer survivorship solutions.
The funding led by .406 Ventures enables further development and scalability of OncoveryCare’s approach, addressing critical needs in survivorship care and intending to achieve better outcomes and reduced costs for cancer survivors.
R. P.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de OncoveryCare